Synthetic Cannabinoids

Synthetic Cannabinoids

Synthetic Cannabinoids

K2 / K3 / K2P (Pinaca)

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test:  10, 25, 50 ng/mL

Rapid Oral Fluid Test:  10 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What are Synthetic Cannabinoids?

Synthetic cannabinoids—often referred to as K2, Spice, K3, K2P, or “herbal incense”—are man-made chemicals designed to activate the same receptors in the brain as THC (the active ingredient in cannabis). However, their chemical structures vary widely, and the compounds evolve frequently as manufacturers attempt to bypass regulations and testing technologies. These substances do not structurally resemble natural cannabis; instead, they belong to diverse chemical classes that can produce unpredictable and sometimes dangerous effects.

Because there is no single “synthetic cannabinoid” formula, researchers classify these substances into several major chemical families, each with its own structural backbone. Newer generations are often modifications of earlier compounds, created to remain legal or avoid detection. This rapid evolution is why toxicology programs, law enforcement, and medical providers struggle to keep up with identification and screening.

These products typically appear as loose, shredded plant-like material in small foil packets, though users may also encounter them in liquid cartridges. They are smoked, vaporized, or occasionally mixed into edibles. The effects are unpredictable because formulations change frequently, and batches often contain mixtures of multiple synthetic chemicals. These substances have no approved medical use and are associated with significant toxicity, including severe agitation, hallucinations, seizures, cardiac events, and fatalities.

Effects:

  • Intense and unpredictable intoxication

  • Severe anxiety, panic, or agitation

  • Hallucinations or psychosis

  • Elevated heart rate and high blood pressure

  • Nausea and vomiting

  • Confusion or disorientation

  • Seizures

  • Kidney damage in severe cases

  • Violent or bizarre behavior

  • High risk of overdose due to unknown potency

Commons Slang Terms:

  • K2

  • Spice

  • Fake weed

  • Synthetic pot

  • Herbal incense

  • Scooby Snax

  • Black Mamba

  • Cloud 9

  • Joker

  • Zombia

Legal Status:

Synthetic cannabinoids are illegal under U.S. federal law, classified broadly under the Controlled Substances Analogue Enforcement Act and scheduled individually as new compounds emerge. Because manufacturers continuously alter chemical formulations to evade regulation, enforcement is challenging—new analogs may be illegal in practice, even if not yet listed by name.

For point-of-care rapid toxicology testing programs, synthetic cannabinoids present significant challenges. Their constantly changing chemistry makes widespread rapid screening difficult, and most routine POC devices do not detect all forms. Some specialty tests exist, but they are more often laboratory-based. Programs relying on POC screening may miss new or uncommon analogs, increasing the importance of:

  • Clear policies addressing suspected impairment

  • Laboratory confirmation when synthetic cannabinoid use is suspected

  • Awareness that negative results do not rule out use due to limited cross-reactivity

Testing organizations, treatment centers, and government programs must stay updated on emerging analogs and understand the limitations of POC screening in detecting these rapidly evolving compounds.

Screening Options:

LEGEND

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Oral Fluid Testing Options Available

 

Lab Confirmation Services Available

Synthetic Cannabinoids

Morphine

Morphine

MOP

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 300, 500, 1,000 ng/mL

Rapid Oral Fluid Test: 25 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Rapid Oral Fluid Test: 48 Hours

What is Morphine?

Morphine is a potent opioid analgesic derived from the opium poppy and is classified as a Schedule II controlled substance in the U.S. Medically, it is prescribed to manage moderate to severe pain, particularly in post-operative care, trauma settings, cancer pain, and palliative care. Pharmaceutical morphine is available as tablets, capsules, oral solutions, and injectable formulations, often appearing as white or colored tablets, clear liquids, or sterile solutions in vials.

Illicit or recreational morphine typically originates from diverted prescription supplies. Users may swallow, crush and snort pills, or inject liquid formulations to achieve rapid euphoria and sedation. Recreational misuse carries high risk due to morphine’s strong respiratory-depressant effects and its significant potential for dependence and overdose.

Effects:

  • Pain relief and reduced perception of discomfort

  • Euphoria or sense of well-being

  • Drowsiness and sedation

  • Slowed breathing and decreased respiratory drive

  • Constricted (pinpoint) pupils

  • Nausea or vomiting

  • Constipation

  • Itching or flushed skin

  • Impaired coordination and mental clouding

  • Risk of dependence, tolerance, and withdrawal

Common Slang Terms:

  • M

  • Miss Emma

  • Dreamer

  • God’s Drug

  • Morph

  • Unkie

  • Monkey

  • White stuff

  • Emsel

  • First line

Legal Status:

Morphine’s classification as a Schedule II controlled substance reflects its accepted medical usefulness but also its high potential for abuse, dependence, and diversion. Because morphine is a primary opioid marker, it is routinely included in standard drug-testing panels for workplaces, treatment centers, government programs, and correctional settings. In point-of-care rapid toxicology devices, morphine is typically detected as part of the OPI (opiate) drug class, which also encompasses codeine and certain metabolites.

In testing environments, a positive morphine screen can indicate illicit opioid use, legitimate prescription use, or metabolite overlap from related substances (e.g., heroin metabolizes into morphine). Therefore, POC programs must follow consistent procedures for confirmation testing to differentiate medical exposure from non-prescribed or illicit use. This ensures compliance with regulatory standards—especially in DOT-regulated or safety-sensitive industries—and supports accurate, defensible decision-making.

Screening Options:

LEGEND

 

CLIA-Waived Testing Options Available

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Oral Fluid Testing Options Available

 

Urine Dip Card Test Options Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Synthetic Cannabinoids

Rohyphnol (Flunitrazepam)

Rohyphnol

BZO (Flunitrazepam)

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 300 ng/mL

Rapid Oral Fluid Test: 3 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What is Rohyphnol?

Rohypnol, the brand name for flunitrazepam, is a powerful benzodiazepine known for its strong sedative, muscle-relaxant, and amnesic properties. It is significantly more potent than most other benzodiazepines. Although widely used in some countries for treating severe insomnia or as a pre-anesthetic medication, Rohypnol is not approved for medical use in the United States due to its high abuse potential and strong central nervous system–depressant effects.

Rohypnol typically appears as small tablets, historically white but more recently green with a blue dye that dissolves into liquids to discourage covert use. In illicit settings, the drug may be crushed, dissolved, or swallowed. Recreational misuse is often driven by its intense sedative and calming effects or by its ability to enhance or modulate other substances, such as alcohol or opioids. Illicit use is strongly associated with sexual assault cases because of its capacity to cause profound sedation, disorientation, and anterograde amnesia.

Effects:

  • Extreme sedation and drowsiness

  • Muscle relaxation and decreased motor control

  • Reduced anxiety and a sense of calm

  • Impaired judgment and slowed reaction time

  • Slurred speech and dizziness

  • Significant memory impairment or blackouts

  • Confusion and disorientation

  • Decreased coordination and balance

  • Respiratory depression at high doses or when mixed with alcohol

  • Risk of dependence, withdrawal, and dangerous polydrug interactions

Commons Slang Terms:

  • Roofies

  • Rophies

  • Roche

  • Forget-me pills

  • La Rocha

  • R2

  • Rope

Legal Status:

Rohypnol is classified in the U.S. as a Schedule IV controlled substance, but with additional restrictions because it has no approved medical use. Possession, distribution, or importation is illegal, and the drug is closely associated with criminal investigations involving drug-facilitated assault. Despite its restricted status, it remains accessible in some countries and is trafficked illicitly.

For rapid toxicology testing programs—including workplace testing, treatment facilities, probation programs, and emergency departments—Rohypnol falls under the broader benzodiazepine class. Most point-of-care tests do not detect flunitrazepam specifically, but it may be detected as part of a general benzodiazepine screen depending on the test’s sensitivity and cross-reactivity. Because of its legal standing and association with criminal misuse, positive screens typically require laboratory confirmation and may prompt further investigation. POC programs must ensure testing policies address benzodiazepines clearly, including documentation procedures and confirmatory pathways.

Screening Options:

LEGEND

 

CLIA-Waived Testing Options Available

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Oral Fluid Testing Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Synthetic Cannabinoids

Oxycodone

Oxycodone

OXY

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 20, 100 ng/mL

Rapid Oral Fluid Test: 5 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What is Oxycodone?

Oxycodone is a semi-synthetic opioid medication derived from thebaine and used medically for moderate to severe pain management. It is available in immediate-release and extended-release formulations (e.g., OxyContin®, Roxicodone®), and typically appears as tablets or capsules in various colors, sizes, and imprints depending on manufacturer. In clinical use, it is taken orally under strict medical supervision due to its high abuse potential.

Recreationally, oxycodone may be swallowed, crushed and snorted, or—in more serious misuse cases—dissolved and injected to intensify its euphoric and sedative effects. Because it directly activates the brain’s opioid receptors, oxycodone carries significant risks for dependence, respiratory depression, overdose, and transition to stronger illicit opioids if misused.

Effects:

  • Pain relief and relaxation

  • Euphoria or a sense of well-being

  • Drowsiness and sedation

  • Slowed breathing and respiratory depression

  • Constricted “pinpoint” pupils

  • Nausea or vomiting

  • Itching or flushed skin

  • Impaired coordination and slowed reaction time

  • Constipation

  • High risk of tolerance, dependence, and withdrawal symptoms

Commons Slang Terms:

  • Oxy

  • Oxys

  • OC

  • Percs / Percocets

  • Hillbilly heroin

  • Blues (for certain 30 mg tablets)

  • Roxy / Roxies

  • 80s (referring to OxyContin® 80 mg, historically)

Legal Status:

Oxycodone is classified as a Schedule II controlled substance in the United States, meaning it is legal only with a valid prescription but has a high potential for abuse, addiction, and diversion. Because of this scheduling, oxycodone is routinely included in standard drug-testing panels for workplaces, treatment programs, court-ordered monitoring, and other supervised environments.

In point-of-care (POC) rapid toxicology testing programs, oxycodone often requires its own dedicated test line, as standard opiate screens may not reliably detect it due to its chemical structure. This makes targeted oxycodone assays valuable for identifying misuse versus prescribed medical use. Any presumptive positive at the POC level typically requires laboratory confirmation to verify accuracy and to distinguish legitimate prescriptions from non-medical use.

Its controlled status also means that programs must document prescription disclosures, maintain strict chain-of-custody procedures, and apply consistent policies when evaluating positive results to ensure compliance with federal and employer standards.

Screening Options:

LEGEND

 

CLIA-Waived Testing Options Available

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Oral Fluid Testing Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Synthetic Cannabinoids

Kratom: Mitragyna Speciosa

Kratom

KRA

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 250 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 7 Days

What is Kratom?

Kratom (Mitragyna speciosa) is a tropical tree native to Southeast Asia whose leaves contain psychoactive alkaloids, primarily mitragynine and 7-hydroxymitragynine. Depending on dosage, kratom can act as either a stimulant or an opioid-like depressant. At low doses, it produces increased energy and alertness; at higher doses, it can create sedation and euphoria similar to opioids.

Kratom is sold in many forms, including powders, capsules, extracts, and pressed tablets. The powder is typically green or brown and may be brewed as tea, swallowed in capsule form, or mixed with other beverages. While kratom has been used traditionally for pain relief and fatigue, in Western markets it is often used recreationally, for self-treatment of opioid withdrawal, or for mood enhancement. Because kratom products are unregulated, potency varies widely and may be contaminated with other substances.

Effects:

  • Increased energy and alertness at low doses

  • Euphoria and mood elevation

  • Pain relief

  • Sedation at moderate or high doses

  • Nausea and gastrointestinal discomfort

  • Sweating and flushed skin

  • Itching or mild histamine-like reactions

  • Constipation

  • Risk of tolerance, dependence, and withdrawal

  • Potential respiratory depression when mixed with other sedatives

Commons Slang Terms:

  • K

  • Thang

  • Biak-biak

  • Ketum

  • Herbal speedball

  • Leaf

  • Krypton (refers to adulterated forms)

Legal Status:

Kratom is not currently scheduled at the federal level in the United States, but several states and cities have banned or restricted its sale. The FDA has issued strong warnings about kratom products, classifying them as unsafe due to contamination risks and opioid-like properties. Because kratom is not a federally controlled substance, most workplace and government-run drug-testing programs do not include kratom in standard screening panels.

Point-of-care rapid toxicology tests generally do not detect kratom unless a specialized assay is used. For testing programs, this means kratom use may go unnoticed unless it is specifically targeted or unless confirmatory laboratory testing (LC/MS) is ordered. Some employers and treatment programs have begun requesting kratom-specific testing due to concerns about impairment, safety risks, and substitution for opioids. Its ambiguous legal status and increasing prevalence make it an emerging consideration for policy updates in workplaces, courts, and rehabilitation programs.

Screening Options:

LEGEND

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm